AdobeStock 281980629

Analysis of triple-negative breast cancer samples reveals new markers that may aid diagnosis and ultimately treatment

Breast cancer is the most common cancer in females in the UK, with around 56 800 new cases diagnosed every year.

TestaAnalytical Prep Flowmeter

New flow monitoring device aims to enhance preparative HPLC efficiency

Continuous flow rate measurement for improved fraction purity and yield

Vapourtec

Vapourtec launches specialised UV detector for peptide synthesis and flow chemistry

New device aims to enhance efficiency in pharmaceutical research and development

Micronic EFC Refill Rack

Micronic introduces sustainable sample storage solution

New refill rack system aims to reduce laboratory waste

Sphere Fluidics CMChroma

Sphere Fluidics unveils next-generation single-cell analysis platform

Cambridge-based Sphere Fluidics has announced the development of Cyto-Mine Chroma, an advanced iteration of its Cyto-Mine platform for single-cell analysis and isolation. Set to launch in Q1 2025, the new system aims to enhance workflow efficiency in biotherapeutic discovery and development.

BioRad Vericheck

Bio-rad launches new ddPCR kit for AAV vector characterisation

Vericheck ddPCR Empty-Full Capsid Kit aims to enhance gene therapy development

EUROIMMUN alzheimers

Revvity’s EUROIMMUN introduces APOE genotyping assay for Alzheimer’s treatment risk assessment

New diagnostic tool aids in personalised anti-amyloid therapy decisions  

Integra PIPETBOY GENIUS

Integra Biosciences introduces new serological pipet controller with repeat dispense function

Advanced features aim to enhance precision and consistency in laboratory pipetting Integra Biosciences has unveiled its latest serological pipet controller, the PIPETBOY GENIUS. This new instrument introduces a repeat dispense function, designed to improve consistency and precision in laboratory pipetting tasks.  

Asimov gene

Asimov unveils comprehensive AAV gene therapy development platform

New system aims to streamline design and production processes Asimov, a synthetic biology company based in Boston, Massachusetts, has announced the launch of its AAV Edge System, a suite of tools designed to enhance the development of adeno-associated viral (AAV) gene therapies. The system offers an integrated approach to address challenges in safety, efficacy, manufacturability, […]